Literature DB >> 26338881

Direct Transfer From the Referring Hospitals to the Catheterization Laboratory to Minimize Reperfusion Delays for Primary Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.

Lindsay L Anderson1, William J French1, S Andrew Peng1, Amit N Vora1, Timothy D Henry1, Matthew T Roe1, Michael C Kontos1, Christopher B Granger1, Eric R Bates1, Anne Hellkamp1, Tracy Y Wang2.   

Abstract

BACKGROUND: For patients with ST-segment-elevation myocardial infarction (STEMI) requiring interhospital transfer for primary percutaneous coronary intervention, direct transfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI receiving hospital may expedite reperfusion, but can be logistically challenging. METHODS AND
RESULTS: We studied 33,901 STEMI patients transferred for primary percutaneous coronary intervention in the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines from July 2008 to December 2012. The majority of patients were transferred directly to the cath lab (26,510 [78.2%]), and 7391 patients (21.8%) were transferred first to the hospital emergency department/ward. We observed significant interhospital variation in transfer patterns; only 21% of STEMI receiving hospitals routinely transferred >90% of STEMI patients to the cath lab directly. Compared with patients transferred first to the emergency department/ward, STEMI patients transferred to the cath lab had significantly lower first door-to-balloon times (median 191 versus 116 minutes, P<0.0001). After multivariable logistic regression, patients transferred directly to the cath lab also had lower adjusted mortality risk (odds ratio 0.58, 95% confidence interval 0.51-0.66, P<0.0001). Cardiogenic shock, heart failure signs/symptoms, and nonsystem reasons for reperfusion delay were present in 11%, 15%, and 28% of patients transferred first to the emergency department/ward, respectively. The association of direct cath lab transfer with lower mortality persisted after excluding patients with these reasons for delay to primary percutaneous coronary intervention (adjusted odds ratio 0.62, 95% confidence interval 0.46-0.84, P=0.002).
CONCLUSIONS: Direct transfer of STEMI patients to the cath lab for primary percutaneous coronary intervention was associated with significantly faster reperfusion and lower mortality risk compared with transfer first to the emergency department/ward.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  catheterization; direct transfer to catheterization laboratory; heart failure; percutaneous coronary intervention; reperfusion delays

Mesh:

Year:  2015        PMID: 26338881     DOI: 10.1161/CIRCINTERVENTIONS.114.002477

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  7 in total

1.  Development of a Catheterization and Percutaneous Coronary Intervention Registry with a Data Management Approach: A Systematic Review.

Authors:  Alireza Tabatabaei Tabrizi; Hamid Moghaddasi; Reza Rabiei; Babak Sharif-Kashani; And Eslam Nazemi
Journal:  Perspect Health Inf Manag       Date:  2019-01-01

2.  "Door-In to Door-Out" Delay in Patients with Acute ST-Segment Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention in a Metropolitan STEMI Network of a Developing Country.

Authors:  Iwan Dakota; Surya Dharma; Hananto Andriantoro; Isman Firdaus; Siska Suridanda Danny; Dian Zamroni; Basuni Radi
Journal:  Int J Angiol       Date:  2019-12-27

3.  Determining the factors for interhospital transfer in advanced heart failure cases.

Authors:  Koichi Narita; Eisuke Amiya; Masaru Hatano; Junichi Ishida; Shun Minatsuki; Masaki Tsuji; Chie Bujo; Nobutaka Kakuda; Yoshitaka Isotani; Minoru Ono; Issei Komuro
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-14

4.  Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction.

Authors:  Karl Heinrich Scholz; Tim Friede; Thomas Meyer; Claudius Jacobshagen; Björn Lengenfelder; Jens Jung; Claus Fleischmann; Hiller Moehlis; Hans G Olbrich; Rainer Ott; Albrecht Elsässer; Stephen Schröder; Christian Thilo; Werner Raut; Andreas Franke; Lars S Maier; Sebastian Kg Maier
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2018-11-27

5.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.

Authors:  Karl Heinrich Scholz; Sebastian K G Maier; Lars S Maier; Björn Lengenfelder; Claudius Jacobshagen; Jens Jung; Claus Fleischmann; Gerald S Werner; Hans G Olbrich; Rainer Ott; Harald Mudra; Karlheinz Seidl; P Christian Schulze; Christian Weiss; Josef Haimerl; Tim Friede; Thomas Meyer
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

6.  Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.

Authors:  Tetsu Tanaka; Refik Kavsur; Maximilian Spieker; Ralf Westenfeld; Marc Ulrich Becher; Christos Iliadis; Clemens Metze; Patrick Horn; Atsushi Sugiura; Stephan Baldus; Malte Kelm; Georg Nickenig; Roman Pfister
Journal:  Clin Res Cardiol       Date:  2021-07-12       Impact factor: 5.460

7.  Did inter-hospital transfer reduce mortality in patients with acute myocardial infarction in the real world? A nationwide patient cohort study.

Authors:  Mi-Sook Kim; Seong Huan Choi; Jang-Whan Bae; Joongyub Lee; Hyeongsu Kim; Won Kyung Lee
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.